Literature DB >> 7876596

Reducing T cell activation as a therapy for human immunodeficiency virus infection.

L Corey.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7876596     DOI： 10.1093/infdis/171.3.521

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  3 in total

1.  Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.

Authors:  Harriet Mayanja-Kizza; Edward Jones-Lopez; Alphonse Okwera; Robert S Wallis; Jerrold J Ellner; Roy D Mugerwa; Christopher C Whalen
Journal:  J Infect Dis       Date:  2005-02-08       Impact factor: 5.226

2.  Quantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infection.

Authors:  Marjet Elemans; Rodolphe Thiébaut; Amitinder Kaur; Becca Asquith
Journal:  PLoS Comput Biol       Date:  2011-03-03       Impact factor: 4.475

Review 3.  Could a simple surgical intervention eliminate HIV infection?

Authors:  Slobodan Tepic
Journal:  Theor Biol Med Model       Date:  2004-08-31       Impact factor: 2.432
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.